These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 36911725)

  • 1. Autologous Heat Shock Protein Peptide Vaccination for Newly Diagnosed Glioblastoma: Impact of Peripheral PD-L1 Expression on Response to Therapy.
    Bloch O; Lim M; Sughrue ME; Komotar RJ; Abrahams JM; O'Rourke DM; D'Ambrosio A; Bruce JN; Parsa AT
    Clin Cancer Res; 2017 Jul; 23(14):3575-3584. PubMed ID: 28193626
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow.
    Holmström MO; Andersen M; Traynor S; Ahmad SM; Lisle TL; Handlos Grauslund J; Skov V; Kjær L; Ottesen JT; Gjerstorff MF; Hasselbalch HC; Andersen MH
    Front Immunol; 2023; 14():1240678. PubMed ID: 37662956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Strategies for Peptide-Based Vaccines in Hematological Malignancies.
    Klausen U; Holmberg S; Holmström MO; Jørgensen NGD; Grauslund JH; Svane IM; Andersen MH
    Front Immunol; 2018; 9():2264. PubMed ID: 30327655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing immune responses of ESC-based TAA cancer vaccines with a novel OMV delivery system.
    Jin M; Huo D; Sun J; Hu J; Liu S; Zhan M; Zhang BZ; Huang JD
    J Nanobiotechnology; 2024 Jan; 22(1):15. PubMed ID: 38166929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The present and future of peptide vaccines for cancer: single or multiple, long or short, alone or in combination?
    Slingluff CL
    Cancer J; 2011; 17(5):343-50. PubMed ID: 21952285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms.
    Holmström MO; Hasselbalch HC; Andersen MH
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunogenic first-in-human immune modulatory vaccine with PD-L1 and PD-L2 peptides is feasible and shows early signs of efficacy in follicular lymphoma.
    Klausen U; Grønne Dahlager Jørgensen N; Grauslund JH; Munir Ahmad S; Gang AO; Martinenaite E; Weis-Banke SE; Breinholt MF; Novotny GW; Kjeldsen JW; Orebo Holmström M; Pedersen LB; Poulsen CB; Hansen PB; Met Ö; Svane IM; Niemann CU; Pedersen LM; Andersen MH
    Oncoimmunology; 2021; 10(1):1975889. PubMed ID: 38283034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups.
    Rammensee HG; Gouttefangeas C; Heidu S; Klein R; Preuß B; Walz JS; Nelde A; Haen SP; Reth M; Yang J; Tabatabai G; Bösmüller H; Hoffmann H; Schindler M; Planz O; Wiesmüller KH; Löffler MW
    Vaccines (Basel); 2021 Apr; 9(5):. PubMed ID: 33923363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case Report: Long-Term Survival of a Patient with Cerebral Metastasized Ovarian Carcinoma Treated with a Personalized Peptide Vaccine and Anti-PD-1 Therapy.
    Zelba H; Kyzirakos C; Kayser S; Shao B; Reinhardt A; Pieper N; Rabsteyn A; Döcker D; Armeanu-Ebinger S; Kloor M; Hadaschik D; Schulze M; Battke F; Golf A; Biskup S
    Vaccines (Basel); 2024 Apr; 12(4):. PubMed ID: 38675779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune profiling of responses to influenza vaccination in patients with myeloproliferative neoplasms.
    Bachanová P; How J; Dzeng R; Mukherjee S; Pavlovic M; Lombardi J; Hobbs G; Reeves PM
    EJHaem; 2024 Jun; 5(3):573-577. PubMed ID: 38895092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginase-1 specific CD8+ T cells react toward malignant and regulatory myeloid cells.
    Glöckner HJ; Martinenaite E; Landkildehus Lisle T; Grauslund J; Ahmad S; Met Ö; Thor Straten P; Hald Andersen M
    Oncoimmunology; 2024; 13(1):2318053. PubMed ID: 38404966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms.
    Hasselbalch HC; Junker P; Skov V; Kjær L; Knudsen TA; Larsen MK; Holmström MO; Andersen MH; Jensen C; Karsdal MA; Willumsen N
    Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial.
    Jørgensen NG; Klausen U; Grauslund JH; Helleberg C; Aagaard TG; Do TH; Ahmad SM; Olsen LR; Klausen TW; Breinholt MF; Hansen M; Martinenaite E; Met Ö; Svane IM; Knudsen LM; Andersen MH
    Front Immunol; 2020; 11():595035. PubMed ID: 33240282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic JAK2
    Prestipino A; Emhardt AJ; Aumann K; O'Sullivan D; Gorantla SP; Duquesne S; Melchinger W; Braun L; Vuckovic S; Boerries M; Busch H; Halbach S; Pennisi S; Poggio T; Apostolova P; Veratti P; Hettich M; Niedermann G; Bartholomä M; Shoumariyeh K; Jutzi JS; Wehrle J; Dierks C; Becker H; Schmitt-Graeff A; Follo M; Pfeifer D; Rohr J; Fuchs S; Ehl S; Hartl FA; Minguet S; Miething C; Heidel FH; Kröger N; Triviai I; Brummer T; Finke J; Illert AL; Ruggiero E; Bonini C; Duyster J; Pahl HL; Lane SW; Hill GR; Blazar BR; von Bubnoff N; Pearce EL; Zeiser R
    Sci Transl Med; 2018 Feb; 10(429):. PubMed ID: 29467301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginase-1 targeting peptide vaccine in patients with metastatic solid tumors - A phase I trial.
    Lorentzen CL; Martinenaite E; Kjeldsen JW; Holmstroem RB; Mørk SK; Pedersen AW; Ehrnrooth E; Andersen MH; Svane IM
    Front Immunol; 2022; 13():1023023. PubMed ID: 36330525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide emulsions in incomplete Freund's adjuvant create effective nurseries promoting egress of systemic CD4
    Melssen MM; Fisher CT; Slingluff CL; Melief CJM
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36939214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
    Iversen TZ
    Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial.
    Grauslund JH; Holmström MO; Martinenaite E; Lisle TL; Glöckner HJ; El Fassi D; Klausen U; Mortensen REJ; Jørgensen N; Kjær L; Skov V; Svane IM; Hasselbalch HC; Andersen MH
    Front Immunol; 2023; 14():1117466. PubMed ID: 36911725
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.